drugset / Trial / NCT00087516
Monotherapy Study in Patients With Type 2 Diabetes Mellitus (0431-021)
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this clinical study is to determine the safety and efficacy of an investigational drug in patients with type 2 diabetes mellitus.
Timeline
- Start
- 2004-06
- Primary completion
- 2005-07
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Sitagliptin | Small molecule | 100 mg | Oral |
| Comparator | Sitagliptin | Small molecule | 200 mg | Oral |
| Comparator | Metformin | Small molecule | 500 mg | Oral |
| Comparator | Metformin | Small molecule | 850 mg | Oral |
| Comparator | Metformin | Small molecule | 1000 mg | Oral |